デフォルト表紙
市場調査レポート
商品コード
1379195

ライフサイエンスBPO市場:サービスタイプ別、用途別、地域別、2023-2028年

Life Sciences BPO Market Report by Service Type (Pharmaceutical Outsourcing, Medical Devices Outsourcing, Contract Sales and Marketing Outsourcing), Application (Clinical Trials, Patient-Centric, R&D Activities, Digital Era), and Region 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
ライフサイエンスBPO市場:サービスタイプ別、用途別、地域別、2023-2028年
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界のライフサイエンスBPO市場規模は、2022年に3,804億7,000万米ドルに達しました。今後、IMARC Groupは、同市場が2028年までに6,251億3,000万米ドルに達し、2022~2028年の成長率(CAGR)は8.6%に達すると予測しています。効率的かつ効果的な問題解決と管理に対するニーズの高まり、研究開発(R&D)活動への注力の強化、急速な技術進歩、ヘルスケア産業の著しい成長が、市場を牽引する主な要因のひとつです。

ライフサイエンスBPO(ビジネスプロセスアウトソーシング)は、ライフサイエンス業界のさまざまなビジネスプロセスや機能を第三者プロバイダーにアウトソーシングするものです。組織の運営と成長をサポートする専門的なサービスを提供します。臨床試験、ファーマコビジランス、メディカルライティング、データ管理などで広く利用されています。ライフサイエンスBPOは、専門知識の活用、コスト削減、業務効率化、拡張性、法規制コンプライアンスの向上など、さまざまなメリットを提供します。ライフサイエンスBPOは、医薬品、バイオテクノロジー、医療機器、臨床研究、ヘルスケアなど、ライフサイエンス分野の企業の業務、研究開発、製造、法規制遵守をサポートする幅広い活動とサービスを包含しています。

ライフサイエンスBPO市場の動向:

世界中で慢性疾患が増加していることが、市場成長を促進する主な要因の1つです。ライフサイエンスBPOプロバイダーは、複雑なヘルスケアデータの収集、分析、整理、報告を支援します。これに伴い、BPOサービスは疾病パターン、治療結果、患者集団に関するより良い洞察を可能にし、個別化医療とエビデンスに基づくヘルスケアソリューションの市場開拓に貢献します。これとは別に、クラウドコンピューティング、ビッグデータ分析、人工知能(AI)、ロボットによるプロセス自動化(RPA)などの急速な技術進歩により、BPOプロバイダーは高度なデータ管理、分析、自動化ソリューションを提供できるようになり、市場成長に弾みをつけています。さらに、ライフサイエンスBPOは、インフラ構築、人材派遣、トレーニング、メンテナンスに関連する運用コストを削減することで、企業にコスト削減の機会を提供しており、これが市場成長にプラスの影響を与えています。その他の要因としては、効率的かつ効果的な問題解決と管理に対するニーズの高まり、研究開発(R&D)活動への注力の強化、情報技術(IT)環境の複雑化、ファーマコビジランス分野の著しい成長などが挙げられ、市場成長の原動力になると予想されます。

本レポートで扱う主な質問

  • 世界のライフサイエンスBPO市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • 世界のライフサイエンスBPO市場における市場促進要因、市場抑制要因、市場機会は何か?
  • それぞれの促進要因、市場抑制要因、機会が世界のライフサイエンスBPO市場に与える影響は?
  • 主要な地域市場とは?
  • 最も魅力的なライフサイエンスBPO市場はどの国か?
  • サービスタイプ別の市場内訳は?
  • ライフサイエンスBPO市場で最も魅力的なサービスタイプは?
  • 用途別の市場内訳は?
  • ライフサイエンスBPO市場で最も魅力的な用途は?
  • 世界のライフサイエンスBPO市場の競争構造は?
  • ライフサイエンスBPOの世界市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 ライフサイエンスBPOの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:サービスタイプ別

  • 医薬品アウトソーシング
  • 医療機器アウトソーシング
  • 販売・マーケティングアウトソーシング

第7章 市場内訳:用途別

  • 臨床試験
    • 市場動向
    • 市場予測
  • 患者中心
    • 市場動向
    • 市場予測
  • 研究開発活動
    • 市場動向
    • 市場予測
  • デジタル時代
    • 市場動向
    • 市場予測

第8章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第9章 促進要因・抑制要因・機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Accenture plc
    • Cognizant
    • Genpact Ltd.
    • IQVIA Inc.
図表

List of Figures

  • Figure 1: Global: Life Sciences BPO Market: Major Drivers and Challenges
  • Figure 2: Global: Life Sciences BPO Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Life Sciences BPO Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Life Sciences BPO Market: Breakup by Service Type (in %), 2022
  • Figure 5: Global: Life Sciences BPO Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Life Sciences BPO Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Life Sciences BPO (Pharmaceutical Outsourcing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Life Sciences BPO (Pharmaceutical Outsourcing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 9: Global: Life Sciences BPO (Medical Devices Outsourcing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Life Sciences BPO (Medical Devices Outsourcing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Life Sciences BPO (Contract Sales and Marketing Outsourcing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Life Sciences BPO (Contract Sales and Marketing Outsourcing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Life Sciences BPO (Clinical Trials) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Life Sciences BPO (Clinical Trials) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Life Sciences BPO (Patient-Centric) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Life Sciences BPO (Patient-Centric) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Life Sciences BPO (R&D Activities) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Life Sciences BPO (R&D Activities) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Life Sciences BPO (Digital Era) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Life Sciences BPO (Digital Era) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: North America: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: North America: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: United States: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: United States: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Canada: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Canada: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Asia-Pacific: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Asia-Pacific: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: China: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: China: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Japan: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Japan: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: India: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: India: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: South Korea: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: South Korea: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Australia: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Australia: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Indonesia: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Indonesia: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Others: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Others: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Europe: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Europe: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Germany: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Germany: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: France: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: France: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: United Kingdom: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: United Kingdom: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Italy: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Italy: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Spain: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Spain: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Russia: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Russia: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Latin America: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Latin America: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Brazil: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Brazil: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Mexico: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Mexico: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Middle East and Africa: Life Sciences BPO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Middle East and Africa: Life Sciences BPO Market: Breakup by Country (in %), 2022
  • Figure 69: Middle East and Africa: Life Sciences BPO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Global: Life Sciences BPO Industry: Drivers, Restraints, and Opportunities
  • Figure 71: Global: Life Sciences BPO Industry: Value Chain Analysis
  • Figure 72: Global: Life Sciences BPO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Life Sciences BPO Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Life Sciences BPO Market Forecast: Breakup by Service Type (in Million US$), 2023-2028
  • Table 3: Global: Life Sciences BPO Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Life Sciences BPO Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Life Sciences BPO Market: Competitive Structure
  • Table 6: Global: Life Sciences BPO Market: Key Players
目次
Product Code: SR112023A11192

Abstract

The global life sciences BPO market size reached US$ 380.47 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 625.13 Billion by 2028, exhibiting a growth rate (CAGR) of 8.6% during 2022-2028. The growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, rapid technological advancements, and significant growth in the healthcare industry represent some of the key factors driving the market.

Life sciences business process outsourcing (BPO) involves outsourcing various business processes and functions to a third-party provider in the life sciences industry. It provides specialized services to support the operations and growth of organizations. It is widely used in clinical trials, pharmacovigilance, medical writing, and data management. Life sciences BPO offers various advantages, including access to specialized expertise, cost savings, operational efficiency, scalability, and improved regulatory compliance. It encompasses a broad range of activities and services that support the operations, research, development, manufacturing, and regulatory compliance of companies in the life sciences field, which includes pharmaceuticals, biotechnology, medical devices, clinical research, and healthcare.

Life Sciences BPO Market Trends:

The increasing prevalence of chronic diseases across the globe is one of the key factors driving the market growth. Life sciences BPO providers help to collect, analyze, organize, and report complex healthcare data. In line with this, BPO services enable better insights into disease patterns, treatment outcomes, and patient populations, contributing to the development of personalized medicine and evidence-based healthcare solutions, which in turn is favoring the market growth. Apart from this, rapid technological advancements, such as cloud computing, big data analytics, artificial intelligence (AI), and robotic process automation (RPA), enable BPO providers to offer advanced data management, analytics, and automation solutions are providing an impetus to the market growth. Moreover, life sciences BPO offers cost-saving opportunities for companies by reducing operational costs associated with infrastructure setup, staffing, training, and maintenance, which is positively influencing the market growth. Other factors, including the growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, the increasing complexity of the information technology (IT) environment, and significant growth in the pharmacovigilance sector, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global life sciences BPO market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on service type and application.

Service Type Insights:

Pharmaceutical Outsourcing

Contract Manufacturing Organizations

API

Finished Dose Form

Packaging

Contract Research Organizations

Drug Discovery

Preclinical Studies

Clinical Trial Studies

Regulatory Services

Pharmacovigilance

Medical Devices Outsourcing

Contract Manufacturing Organizations

Electronic Manufacturing Services

Finished Goods

Raw Materials/ Components

Contract Research Organizations

Regulatory Consulting Services

Product Design and Development Services

Product Testing Services

Product Upgrade Services

Product Maintenance Services

Contract Sales and Marketing Outsourcing

The report has provided a detailed breakup and analysis of the life sciences BPO market based on the service type. This includes pharmaceutical outsourcing {contract manufacturing organizations (API, finished dose form, and packaging) and contract research organizations (drug discovery, preclinical studies, clinical trial studies, regulatory services, and pharmacovigilance)}, medical devices outsourcing {contract manufacturing organizations (electronic manufacturing services, finished goods, and raw materials/ components), and contract research organizations (regulatory consulting services, product design and development services, product testing services, product upgrade services, and product maintenance services)}, and contract sales and marketing outsourcing. According to the report, pharmaceutical outsourcing represented the largest segment.

Application Insights:

Clinical Trials

Patient-Centric

R&D Activities

Digital Era

A detailed breakup and analysis of the life sciences BPO market based on the application has also been provided in the report. This includes clinical trials, patient-centric, R&D activities, and digital era.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific was the largest market for life sciences BPO. Some of the factors driving the Asia Pacific life sciences BPO market included the growing need for efficient and effective problem resolution and management, enhanced focus on research and development (R&D) activities, and rapid technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global life sciences BPO market. Detailed profiles of all major companies have been provided. Some of the companies covered include Accenture plc, Cognizant, Genpact Ltd., IQVIA Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global life sciences BPO market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global life sciences BPO market?
  • What is the impact of each driver, restraint, and opportunity on the global life sciences BPO market?
  • What are the key regional markets?
  • Which countries represent the most attractive life sciences BPO market?
  • What is the breakup of the market based on service type?
  • Which is the most attractive service type in the life sciences BPO market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the life sciences BPO market?
  • What is the competitive structure of the global life sciences BPO market?
  • Who are the key players/companies in the global life sciences BPO market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Life Sciences BPO Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Service Type

  • 6.1 Pharmaceutical Outsourcing
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Contract Manufacturing Organizations
        • 6.1.2.1.1 API
        • 6.1.2.1.2 Finished Dose Form
        • 6.1.2.1.3 Packaging
      • 6.1.2.2 Contract Research Organizations
        • 6.1.2.2.1 Drug Discovery
        • 6.1.2.2.2 Preclinical Studies
        • 6.1.2.2.3 Clinical Trial Studies
        • 6.1.2.2.4 Regulatory Services
        • 6.1.2.2.5 Pharmacovigilance
    • 6.1.3 Market Forecast
  • 6.2 Medical Devices Outsourcing
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Contract Manufacturing Organizations
        • 6.2.2.1.1 Electronic Manufacturing Services
        • 6.2.2.1.2 Finished Goods
        • 6.2.2.1.3 Raw Materials/ Components
      • 6.2.2.2 Contract Research Organizations
        • 6.2.2.2.1 Regulatory Consulting Services
        • 6.2.2.2.2 Product Design and Development Services
        • 6.2.2.2.3 Product Testing Services
        • 6.2.2.2.4 Product Implementation Services
        • 6.2.2.2.5 Product Upgrade Services
        • 6.2.2.2.6 Product Maintenance Services
    • 6.2.3 Market Forecast
  • 6.3 Contract Sales and Marketing Outsourcing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Clinical Trials
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Patient-Centric
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 R&D Activities
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Digital Era
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Accenture plc
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
    • 13.3.2 Cognizant
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Genpact Ltd.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 IQVIA Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.